For decades, fibromyalgia was misunderstood. Patient symptoms included widespread pain, fatigue, and cognitive issues. Scans and tests often came back normal, which led to confusion, skepticism, and treatments that frequently fell short…but now that understanding is changing.
Recent clinical reporting, including a recent article titled “Fibromyalgia Reframed and Linked to Altered Pain Processing”, describes fibromyalgia as a condition rooted in altered pain processing, not tissue damage (Medscape, 2026).
Fibromyalgia now sits within a newer, third category of pain known as nociplastic pain.
This shift reflects a deeper understanding of limbic and nervous system dysregulation as a driving mechanism behind chronic symptoms.
The Three Types of Pain: A Modern Framework
It helps to look at how pain is now classified to understand why this matters.
The International Association for the Study of Pain (IASP) defines three distinct types of pain: nociceptive, neuropathic, and nociplastic (IASP, 2017).
- Nociceptive Pain: Tissue Damage
Pain caused by injury or inflammation (e.g., burns, sprains, arthritis) is driven by activation of nociceptors in damaged tissue (Basbaum et al., 2009).
Damage → Signal → Pain
- Neuropathic Pain: Nerve Damage
Pain caused by damage or disease of the somatosensory nervous system (IASP, 2017).
Nerve damage → Distorted signals → Pain
- Nociplastic Pain: Altered Processing
Pain caused by altered nociception despite no clear evidence of tissue damage or nerve injury (IASP, 2017).
No damage → Misinterpreted signals → Pain
Fibromyalgia: The Prototypical Nociplastic Condition
Fibromyalgia is now widely recognized as the clearest example of nociplastic pain (Fitzcharles et al., 2021), and according to current research:
- There is no consistent evidence of tissue damage
- There is no structural nerve injury
- Patients experience very real, often severe symptoms
The 2026 Medscape report emphasizes that fibromyalgia should be understood as:
A disorder of altered pain processing (Medscape, 2026)
This aligns with research showing that fibromyalgia involves:
- Amplification of sensory signals in the central nervous system
- Dysregulation in pain-modulating networks
- Heightened sensitivity to both painful and non-painful stimuli (Clauw, 2015; Schmidt-Wilcke & Diers, 2017)
Together, these findings reflect limbic and nervous system dysregulation, a state in which the brain’s threat and stress systems remain chronically activated.
A Critical Turning Point in Understanding
If fibromyalgia is now understood as a disorder of altered pain processing, this raises an important question: can those patterns in the brain be changed?
Emerging research on neuroplasticity suggests that it is possible. (Ashar et al., 2021).
One helpful way to understand nociplastic pain is to think of the nervous system like an alarm system. In a healthy system, the alarm goes off when there is a real threat, e.g., a break-in. This is similar to nociceptive pain, where injury triggers a protective response. In nociplastic pain, the alarm system becomes overly sensitive.
The body’s alarm system is triggered when there is no danger: a gust of wind, a passing car, and small, harmless changes. The alarm is overprotective, not broken. This reflects what researchers describe as central sensitization, where the nervous system amplifies signals and misinterprets safety as threat (Woolf, 2011).
In conditions like fibromyalgia, the brain and nervous system begin to interpret safe signals as actually dangerous. The result is very real pain but without physical damage.
The key insight: you don’t need to fix the body. You need to retrain the body’s alarm system.
The Mechanism: Central Sensitization
At the core of fibromyalgia and nociplastic pain is central sensitization.
This involves: Increased excitability of neurons in the central nervous system, reduced inhibition of pain signals, and amplification of normal sensory input into pain (Woolf, 2011; Nijs et al., 2021).
This state is driven in large part by limbic and nervous system dysregulation, where brain regions involved in threat detection and emotional processing remain persistently activated.
This pattern, the hallmarks of central sensitization, is well documented and as noted in the references directly above.
Pain without clear injury
- Widespread or shifting symptoms
- Heightened sensitivity (allodynia, hyperalgesia)
- Sensitivity to light, sound, chemicals, or temperature
- Symptoms triggered by stress or mental exertion
- Fluctuating and unpredictable symptoms
- Fatigue, brain fog, and sleep disruption
- Limited response to structural treatments
The Key Takeaway
This is the most important takeaway from the new model: not damage, but dysregulation.
Fibromyalgia is not a disease of damaged tissue. It is a condition of limbic and nervous system dysregulation.
Symptoms are driven by:
- Altered, overprotective neural pathways
- Conditioned threat responses
- Reinforced signaling loops
The nervous system has shifted into a persistent state of protection, even when it is no longer necessary. These patterns are not fixed. They are neuroplastic.
A New Direction in Treatment: Retraining the Brain
Traditional treatments often fall short because they focus on the body rather than the brain’s processing systems.
Emerging research supports approaches that:
- Target neural circuitry
- Reduce perceived threat
- Recondition the brain’s response to sensory input
One example is pain reprocessing therapy, which has been demonstrated to reduce chronic pain by altering brain activity patterns (Ashar et al., 2021).
DNRS and the Nociplastic Model of Fibromyalgia
The Dynamic Neural Retraining System (DNRS) aligns with this evolving scientific framework.
DNRS is based on the principle that the brain can be trained out of a chronic “danger” state and back into safety.
From a neuroscience perspective, DNRS targets:
- Limbic system overactivation
- Nervous system dysregulation
- Altered, overprotective neural pathways
These mechanisms mirror those identified in fibromyalgia:
- Central sensitization
- Altered pain processing
- Amplified threat signaling
Conclusion
The reframing of fibromyalgia as nociplastic pain marks a major shift in medicine.
It tells us:
- The pain is real
- The symptoms are valid
- The mechanism is limbic and nervous system dysregulation, not tissue damage
And most importantly:
The same brain that established these protective patterns can also recalibrate them.
References
Basbaum, A. I., et al. (2009). Cellular and molecular mechanisms of pain. Cell.
Clauw, D. J. (2015). Fibromyalgia: A clinical review. JAMA.
Medscape. (2026). Fibromyalgia Reframed and Linked to Altered Pain Processing.
Nijs, J., et al. (2021). Central sensitisation in chronic pain conditions. The Lancet Rheumatology.
Schmidt-Wilcke, T., & Diers, M. (2017). Neuroimaging of fibromyalgia. Current Rheumatology Reports.
